Prebiotics and probiotics as potential therapy for cognitive impairment

Alejandra Romo-Araiza, Antonio Ibarra

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Cognitive functions, such as learning and memory, may be impaired during aging. Age-related cognitive impairment is associated with selective neuronal loss, oxidative changes that lead to microglia activation and neuroinflammation. In addition, it is associated to alteration reduction in trophic factors affecting neurogenesis and synaptic plasticity. In recent years, attention has been paid to the relationship between gut microbiota and brain. In aging, there is an alteration in microbiota, gut microbiota diversity is perturbed with an increase in pathogenic bacteria at the expense of beneficial ones. Dysbiosis may lead to chronic inflammation, and a decrease in bacteria metabolites such as short-chain fatty acids which have been related to an upregulation of neurotrophic factors. Supplementation with prebiotics and probiotics can modulate gut microbiota, returning it to a more physiological state; thus, they may be considered as a possible treatment for age-related cognitive impairment.

Original languageEnglish
Article number109410
JournalMedical Hypotheses
Volume134
DOIs
StatePublished - 1 Jan 2020

Fingerprint

Dive into the research topics of 'Prebiotics and probiotics as potential therapy for cognitive impairment'. Together they form a unique fingerprint.

Cite this